Equitable Holdings’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.2M Buy
22,135
+7,007
+46% +$1.32M 0.03% 506
2026
Q1
$2.98M Buy
15,128
+3,407
+29% +$657K 0.02% 601
2025
Q4
$2.16M Sell
11,721
-242
-2% -$42.4K 0.01% 616
2025
Q3
$1.84M Buy
11,963
+1,177
+11% +$178K 0.01% 643
2025
Q2
$1.51M Buy
10,786
+857
+9% +$120K 0.01% 670
2025
Q1
$1.46M Buy
9,929
+402
+4% +$58.2K 0.01% 602
2024
Q4
$1.25M Buy
9,527
+5,501
+137% +$770K 0.01% 614
2024
Q3
$627K Buy
4,026
+984
+32% +$159K 0.01% 808
2024
Q2
$474K Buy
3,042
+661
+28% +$99.5K 0.01% 847
2024
Q1
$323K Buy
2,381
+197
+9% +$26.1K ﹤0.01% 939
2023
Q4
$294K Sell
2,184
-131
-6% -$17K ﹤0.01% 945
2023
Q3
$314K Buy
2,315
+219
+10% +$29.9K ﹤0.01% 857
2023
Q2
$300K Sell
2,096
-10
-0.5% -$1.47K ﹤0.01% 847
2023
Q1
$292K Buy
2,106
+151
+8% +$20.3K ﹤0.01% 806
2022
Q4
$265K Sell
1,955
-33
-2% -$4.14K ﹤0.01% 769
2022
Q3
$218K Sell
1,988
-8
-0.4% -$1.01K ﹤0.01% 784
2022
Q2
$264K Buy
1,996
+74
+4% +$9.71K 0.01% 732
2022
Q1
$255K Buy
1,922
+24
+1% +$2.88K ﹤0.01% 772
2021
Q4
$221K Sell
1,898
-20
-1% -$2.35K ﹤0.01% 798
2021
Q3
$230K Buy
+1,918
New +$223K ﹤0.01% 762

Other funds holding AZN

Equitable Holdings's AZN Position: Q2 2026 in Review

Equitable Holdings increased its AstraZeneca (AZN) stake by 46% in Q2 2026, buying an estimated $1.32M and bringing the position to 22,135 shares worth $4.2M. The position accounts for 0.03% of the portfolio, ranked #506.

Equitable Holdings first reported a position in AZN in Q3 2021 and has held it in 20 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Equitable Holdings held 22,135 shares of AstraZeneca worth $4.2M as of Q2 2026.
  • Equitable Holdings bought 7,007 AstraZeneca shares in Q2 2026, an estimated $1.32M.
  • AstraZeneca made up 0.03% of Equitable Holdings's portfolio in Q2 2026, its #506 holding.
  • Equitable Holdings first reported a position in AstraZeneca in Q3 2021 and has held it in 20 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.